www.triumf.ca
Open in
urlscan Pro
142.90.89.35
Public Scan
Submitted URL: http://triumf.ca/
Effective URL: https://www.triumf.ca/
Submission Tags: tranco_l324
Submission: On November 14 via api from DE — Scanned from CA
Effective URL: https://www.triumf.ca/
Submission Tags: tranco_l324
Submission: On November 14 via api from DE — Scanned from CA
Form analysis
0 forms found in the DOMText Content
Skip to main content TRIUMF : CANADA'S PARTICLE ACCELERATOR CENTRE Canada's particle accelerator centre Centre canadien d'accélération des particules * facebook * twitter * instagram * youtube * flickr * linkedin * Home * Login * Directory * Research Program * Technical Services * Administration * Quick Links * Login * Directory Home * About TRIUMF * Research Topics * Strategic Plan * Leadership Team * Governance & Management * Partners * History * Alumni - TARA * For the Public * Public Information & Disclosure Program * High School Programs * Saturday Morning Lectures * Tours of TRIUMF * Science through Art * Publications/Gallery * Parking Information * Scientific Events and Lectures * TRIUMF Science Week 2021 * Discover Our Lab * Academic Programs * Proton and Neutron Irradiation (PIF & NIF) * For Scientific Visitors * For the Media * People & Careers * TRIUMF House * TRIUMF Innovations * FINALIZATION OF TRIUMF INCORPORATION Effective June 1, 2021, TRIUMF has successfully completed its transition from a joint venture to a non-profit corporation with charitable status. Read more here. * TRIUMF 20-YEAR VISION DEVELOPMENT PLAN TRIUMF is preparing a 20-year Vision to project TRIUMF’s main activities for the period until ~2042, as well as the need for new facilities and infrastructure to service these activities. Read more here. * TRIUMF COMMUNITY RALLIES IN RESPONSE TO COVID-19 PANDEMIC In the face of the global COVID-19 pandemic, groups from across the TRIUMF community have mobilized to support a variety of health-focused initiatives. * THANK YOU, TRIUMF! As we continue to face the impact of the coronavirus on TRIUMF and the global science community, we want to take a moment to acknowledge the efforts of everyone at the lab doing their part each day. * NEW T2K RESULTS ESTABLISH SIGNIFICANT BOUNDARIES ON NEUTRINO OSCILLATION With results published recently in the prestigious journal Nature, T2K researchers, including several TRIUMF scientists, have have made an important first step in the comparison of neutrino and antineutrino oscillation. * TRIUMF'S FIVE-YEAR PLAN 2020-2025 Our Five-Year Plan 2020-2025 lays out a vision for TRIUMF for the next five years and the decades beyond. It is designed to maximize our impact, build on our existing strengths, and capitalize on emerging opportunities. We invite you to explore our plan. 1. 1 2. 2 3. 3 4. 4 5. 5 6. 6 * Previous * Next HOME ! TRIUMF's latest Coronavirus (COVID-19) advisories and updates are available here [Revised: October 22, 2021] HEADLINES & RESEARCH HIGHLIGHTS TRIUMF’S DRAGON CELEBRATES 20TH ANNIVERSARY 05 November 2021 The DRAGON experiment has been a mainstay in TRIUMF’s scientific portfolio since 2001, measuring the majority of the world’s radiative capture reactions with rare isotope beams so far and, in the process, making a number of first-in-the-world measurements. PROFESSIONAL DEVELOPMENT PROGRAM FOR STUDENTS BRINGS 360° LEARNING FOR TRIUMF CO-OPS 27 October 2021 After more than a year of virtual sessions, TRIUMF’s professional development program for undergraduate students is bringing together the laboratory’s Fall 2021 students for a suite of hands-on, 360° professional development workshops scheduled across the Fall term. E-LINAC TEAMS HIT 2021 COMMISSIONING TARGET AHEAD OF SCHEDULE 13 October 2021 Teams working on TRIUMF’s Advanced Rare Isotope Laboratory (ARIEL) achieved a major milestone for the facility’s electron linear accelerator (e-linac) by reaching an average beam power of 10 kW at the e-linac's design energy of 30 MeV. The results, which come nearly three months ahead of schedule, mark a major leap in the ramp-up of the accelerator’s output to full capacity and eventual operation. TRIUMF AND FUSION PHARMACEUTICALS ANNOUNCE EXPANDED R&D COLLABORATION FOR ACTINIUM SUPPLY PRODUCTION 12 August 2021 The clinical-stage oncology company and TRIUMF announced their entry into the next phase of their collaboration agreement for the production of actinium-225. DR. JENS DILLING TO BECOME DIRECTOR OF INSTITUTIONAL STRATEGIC PLANNING AT ORNL 02 July 2021 After 20 years of service to TRIUMF, Jens Dilling will be departing the laboratory on July 31, 2021 to take on a new challenge as the Director of Institutional Strategic Planning at Oak Ridge National Laboratory in Tennessee. TRIUMF JOINS RADNEXT INFRASTRUCTURE NETWORK 21 June 2021 TRIUMF has joined RADNEXT (‘RADiation facility Network for the EXploration of effects for indusTry and research’), a Horizons 2020 infrastructure project that will establish a global network of facilities and related irradiation methodology for responding to the emerging needs of electronics component and system irradiation. See all Stories UNIVERSITY PARTNERS & OWNERS * About TRIUMF * Research Topics * Strategic Plan * Leadership Team * Governance & Management * Partners * History * Alumni - TARA * For the Public * Public Information & Disclosure Program * High School Programs * Saturday Morning Lectures * Tours of TRIUMF * Science through Art * Publications/Gallery * Parking Information * Scientific Events and Lectures * TRIUMF Science Week 2021 * Discover Our Lab * Academic Programs * Proton and Neutron Irradiation (PIF & NIF) * For Scientific Visitors * For the Media * People & Careers * TRIUMF House * TRIUMF Innovations * Find People * Search the Site * Media * Contact Us * facebook * twitter * instagram * youtube * flickr * linkedin DISCOVERY, ACCELERATED * Home * Login * Directory * Research Program * Technical Services * Administration * Quick Links * Login * Directory * facebook * twitter * instagram * youtube * flickr * linkedin